Valoserdin® (Valoserdin)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbspdrops for ingestion
Composition:

Active substances:

Phenobarbital - 2.00 g

Ethyl bromoisovalerate (ethyl α-bromoisovaleric acid ethyl ester) - 2.00 g

Excipients: - up to 100 g

Mint pepper oil -0.14 g

Spanish hop oil (oregano oil) - 0.02 g

Ethanol (ethyl alcohol) 95% - 52.80 g

Purified Water - 43.04 g

Description:Transparent colorless liquid with a specific aromatic odor.
Pharmacotherapeutic group:Sedative remedy
ATX: & nbsp
  • Other sleeping pills and sedatives
    • Pharmacodynamics:

    Combined drug, the therapeutic effect of which is due to the pharmacological properties of the components that make up its composition. Has a sedative and spasmolytic effect.

    Phenobarbital has sedative and mild hypnotic effects. Helps reduce excitation of the central nervous system and facilitates the onset of natural sleep, enhancing the sedative effect of other components. Ethyl bromizovalerianate also has a sedative (similar to the effect of valerian) and spasmolytic action.

    Indications:Valoserdin® is prescribed as a soothing and vasodilating agent for functional disorders of the cardiovascular system, with neurosis-like conditions, accompanied by increased irritability, disturbed sleep, tachycardia,state of excitation with pronounced vegetative manifestations; as an antispasmodic - for intestinal spasms.
    Contraindications:

    Hypersensitivity to the components of the drug; expressed violations of kidney and / or liver function, pregnancy, the period of breastfeeding, porphyria, children under 18 years of age.

    In connection with the absolute ethyl alcohol content of more than 3.0 g in a daily dose of Valoserdin® is contraindicated in patients with liver disease, alcoholism, craniocerebral trauma and brain diseases.

    Dosing and Administration:

    Inside, before meals, previously dissolved in a small amount (30-50 ml) of water. Adults usually appoint 15-20 drops 3 times a day. With tachycardia, it is possible to increase the single dose to 40-50 drops.

    The duration of the drug is determined individually by the doctor.

    Side effects:Valoserdin®, as a rule, is well tolerated even with prolonged use. In some cases, during daylight hours, drowsiness and lightheadedness may occur. With prolonged use of large doses, it is possible to develop chronic bromine poisoning, which manifestations include: depressive mood, apathy, rhinitis, conjunctivitis, hemorrhagic diathesis, disruption of coordination of movements.If any side effects are observed that are not reflected in the instructions for use, it is necessary to report them to the treating doctor.
    Overdose:

    Symptoms: with mild to moderate intoxication, drowsiness, dizziness, and psychomotor disturbances are observed. In severe cases - coma, lower blood pressure, respiratory failure, tachycardia, vascular collapse, decreased peripheral reflexes.

    Treatment: rinse the stomach, take Activated carbon and call a doctor.

    Interaction:

    With the simultaneous use of Valoserdin® with sedatives - strengthening the effect. Simultaneous use with neuroleptics and tranquilizers strengthens, and with stimulants of the central nervous system - weakens the effect of each of the components of the drug. Alcohol enhances the effects of Valoserdin® and can increase its toxicity. The presence of phenobarbital in the composition can induce liver enzymes, and this makes it undesirable to use it simultaneously with drugs that are metabolized in the liver, since their concentration, and accordingly the effectiveness will decrease as a result of more accelerated metabolism (indirect anticoagulants, antibiotics, sulfonamides, etc.).

    Phenobarbital weakens the action of coumarin derivatives, glucocorticosteroids, griseofulvin, contraceptives for oral administration. Valoserdin® can increase the toxicity of methotrexate.

    Special instructions:

    Before using the drug, you should consult your doctor.

    If it is necessary to prescribe the drug in the period of breastfeeding, the question of stopping breastfeeding should be resolved.

    With prolonged use of the drug, the formation of drug dependence is possible; Possible the accumulation of bromine in the body and the development of poisoning them.

    The preparation contains not less than 52 vol.% Ethanol.

    The maximum single dose of the preparation contains 1.03 g of absolute ethyl alcohol; the maximum daily dose contains 3.09 grams of absolute ethyl alcohol.

    Effect on the ability to drive transp. cf. and fur:When using the drug is not recommended to carry out potentially dangerous activities that require increased concentration of attention and speed of psychomotor reactions (including the management of vehicles, work with moving mechanisms).
    Form release / dosage:Drops for ingestion.
    Packaging:

    For 15 ml, 25 ml and 50 ml in bottles of droppers of orange glass or in bottles of glass made of brown glass with a screw mouth, sealed with stoppers, droppers, polymer caps and polymeric screw caps or caps with a dropper.

    Each vial or dropper along with the instruction for use is placed in a pack of cardboard.

    Storage conditions:

    Store in a dark place at a temperature not exceeding 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    3 years.

    Do not use the drug after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:P N000624 / 01
    Date of registration:07.08.2007 / 15.07.2013
    Expiration Date:Unlimited
    The owner of the registration certificate:MOSCOW PHARMACEUTICAL FACTORY, CJSC MOSCOW PHARMACEUTICAL FACTORY, CJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp19.01.2017
    Illustrated instructions
      Instructions
      Up